USD 1.84 billion
Contrast Enhanced Mammography Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres, Specialty Clinics, Others), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35G2123 |
Region:
Global |
Published Date: July, 2024
Pages:
219
|Tables:
62
|Figures:
78
Contrast Enhanced Mammography Market Insights
Contrast Enhanced Mammography Market size was valued at USD 1.94 Billion in 2023 and is poised to grow from USD 2.04 Billion in 2024 to USD 3.07 Billion by 2032, growing at a CAGR of 5.28% during the forecast period (2025-2032).
Using a dual-energy technique, contrast-enhanced mammography (CEM) combines the benefits of digital mammography with intravenous contrast. CEM is more sensitive than full-field digital mammography (FFDM) alone and FFDM combined with ultrasound for detecting breast cancer in the diagnostic setting.
Due to the rising prevalence of breast cancer worldwide, Contrast Enhanced Mammography (CEM) has become a highly popular and most commonly used technique. Factors that increase the risk of breast cancer include age, obesity, harmful alcohol use, family history of breast cancer, radiation exposure history, reproductive history (age at first menstrual cycle and first pregnancy), tobacco use, and postmenopausal hormone therapy. Majority of breast cancer cases occur in females, affecting a large proportion of the population. It is mostly found in the breast tissues that breast cancer develops. There are several symptoms of breast cancer, such as lumps in the breast, changes in the size and shape of the breast, fluid coming out of the nipple, and itchiness, scaliness, and redness on the skin. In addition to pain in the bones, swelling of lymph nodes, breathing problems, and other symptoms, this disorder causes the disease to spread. As a result, breast cancer prevalence is on the rise throughout the world, driving market growth.
US Contrast Enhanced Mammography Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Hospital
Fastest Growth
Hospital
Growth Rate
5.28% CAGR
Global Contrast Enhanced Mammography Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
To get more reports on the above market click here to Buy The Report
Contrast Enhanced Mammography Market Segmental Analysis
Global Contrast Enhanced Mammography Market is segmented based on Applications, End User, and region. Based on Applications the Contrast Enhanced Mammography Market is segmented into Screening, and Diagnosis. Based on End User the market is segmented into Hospital, Diagnostic Centres, Specialty Clinics, Others. Based on region the global Contrast Enhanced Mammography Market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.
Contrast Enhanced Mammography Market Analysis by End User
The hospitals segment dominated the global market in 2022. As patients are hospitalized more frequently and the disease burden increases, the segment is expected to grow. Additionally, PET, CT, and MRI are used to monitor disease progression and assess the effectiveness of cancer treatments. However, due to the increasing number of initiatives undertaken by governments to provide various services, such as reimbursement for diagnostic tests, the segment of diagnostic centers is expected to grow significantly over the forecast period.
Global Contrast Enhanced Mammography Market By End User, 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Contrast Enhanced Mammography Market Regional Insights
The North America region is anticipated to dominate the global contrast enhanced mammography market. The presence of large players, established diagnostic and screening infrastructure, technological breakthroughs, high patient awareness, and reimbursement regulations are the main drivers of this region's dominance.
Due to the rising incidence of breast cancer and the adoption of cutting-edge diagnostic methods, the market in Asia Pacific region is anticipated to experience the greatest CAGR over the forecast period. Additionally, it is anticipated that expanding healthcare infrastructure and bettering reimbursement policies will promote market growth.
Global Contrast Enhanced Mammography Market By Geography, 2022-2030
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Contrast Enhanced Mammography Market Dynamics
Contrast Enhanced Mammography Market Drivers
- The major factor driving the market growth is rising incidence of breast cancer. Breast cancer is the most common cancer among women worldwide. It is possible to treat breast cancer extremely effectively, especially if the disease is diagnosed early. A breast cancer patient is generally treated with surgery, radiation therapy, and medications (hormone therapy, chemotherapy, and/or targeted biological therapy) to treat the microscopic cancer that has spread from the breast tumor. Treatments such as these can prevent cancer growth and spread, thereby saving lives.
- According to World Health Organization (WHO) 685 000 people worldwide died in 2020 as a result of breast cancer, which affected 2.3 million women. The most common cancer in the globe as of the end of 2020 was breast cancer, which had been diagnosed in 7.8 million women in the previous five years. Worldwide, breast cancer causes more lost disability-adjusted life years (DALYs) for women than any other type of cancer. Every country in the globe experiences breast cancer in women after puberty at any age, albeit the incidence rates rise as people age. Also, merely gender (female) and age, the only known risk factors for breast cancer in women, account for almost half of all cases (over 40 years). Ageing, obesity, drinking too much alcohol, radiation exposure history, family history of breast cancer, reproductive history (such as age at first pregnancy and age at first menstruation), smoking, and postmenopausal hormone therapy are some variables that raise the risk of breast cancer. However, even if all of the possibly controllable risk factors could be avoided, the risk of developing breast cancer would only be decreased by a maximum of 30%. Thus, increasing prevalence of breast cancer is increasing the demand for Contrast Enhanced Mammography, in turn driving the market.
Contrast Enhanced Mammography Market Restraints
- Contrast-enhanced mammography is a relatively new technology, and its cost is higher than traditional mammography. The high cost of equipment, materials, and training needed for contrast-enhanced mammography can be a significant barrier to its adoption. Also, Contrast-enhanced mammography is not widely available, and the number of facilities that offer this technology is still limited. This can make it challenging for patients to access this type of imaging, particularly in rural or remote areas. Moreover, regulatory approval is required before contrast-enhanced mammography can be used in clinical practice. This approval process can be lengthy and expensive, and may delay the introduction of this technology to the market. In addition, although contrast-enhanced mammography has shown promising results in clinical studies, there is still a lack of long-term data on its effectiveness and safety. This can make some healthcare providers hesitant to adopt this technology until more evidence is available.
Request Free Customization of this report to help us to meet your business objectives.
Contrast Enhanced Mammography Market Competitive Landscape
Some of the major players engaged in the market are Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Medical Systems, Planmed Oy. Other players include, Metaltronica, Carestream Health, and General Medical Merate. The market is also experiencing the entry of new players, which is expected to intensify competition in the coming years.
Contrast Enhanced Mammography Market Top Player’s Company Profiles
- Hologic Inc.
- GE Healthcare
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Fujifilm Holdings Corporation
- Dilon Technologies Inc.
- Planmed Oy
- Metaltronica S.p.A.
- CMR Naviscan Corporation
- General Medical Merate S.p.A.
- Delphinus Medical Technologies Inc.
- Micrima Limited
- KUB Technologies Inc.
- Aurora Imaging Technology Inc.
- Carestream Health Inc.
- Planmed Oy
- Zebra Medical Vision Ltd.
- Volpara Health Technologies Ltd.
- iCAD Inc.
- Agfa-Gevaert NV
Contrast Enhanced Mammography Market Recent Developments
- In October 2023, Hologic and Bayer announced a collaborative effort to advance contrast-enhanced mammography (CEM) adoption across Asia Pacific, Canada, and Europe. This pioneering technique involves administering iodinated contrast intravenously and utilizing both low-energy and high-energy X-rays, akin to digital mammography. The iodine selectively absorbs high-energy X-rays, potentially improving cancer detection accuracy.
- In October 2023, Syracuse became the hub for cutting-edge breast cancer imaging technology with the installation of two 3-D mammography units at Crouse Hospital. This state-of-the-art technology aims to detect cancerous tumors at earlier stages and enhance cancer detection in denser breast tissue.
- In June 2023, Bayer announced that its iodine-based contrast agent, Ultravist (iopromide)-300, -370, received approval from the U.S. Food and Drug Administration (FDA) for contrast-enhanced mammography (CEM). This approval makes Ultravist the only contrast agent authorized for this specific indication. The product is intended for visualizing known or suspected breast lesions in adults, serving as an adjunct to mammography and/or ultrasound. CEM is an emerging imaging modality that combines digital mammography with the administration of a contrast agent like Ultravist to aid in the identification of breast lesions.
Contrast Enhanced Mammography Key Market Trends
- Every year, the incidence of breast cancer in women rises, along with the market expansion and the number of treatments available. Enhanced techniques for breast cancer diagnostics using advanced technologies. More sophisticated technologies for the early detection of breast cancer have improved performance in terms of efficiency, accuracy, efficacy, dependability, and speed of results.
- For quicker cancer detection, improved characteristics have been developed. Early cancer detection helps patients recover more quickly, stops the malignant cells from spreading to other body areas, and allows for treatment with the most recent drugs on the market. Breast cancer screening and tumor imaging are increasing, which boosts the market.
- Increased funding from the major market players for the development of medications and treatments as well as increased research for diagnosing the disorder with greater efficacy and in a shorter amount of time. Increased research and development with an increase in the number of treatments introduced by the major market players in the breast market.
Contrast Enhanced Mammography Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global contrast enhanced mammography market analysis, rising prevalence of breast cancer across the globe, increasing approvals for new technologies, surging investments by government as well as major key players are driving market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.94 Billion |
| Market size value in 2032 | USD 3.07 Billion |
| Growth Rate | 5.28% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
Contrast Enhanced Mammography Market Recent Developments
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Contrast Enhanced Mammography Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Contrast Enhanced Mammography Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Contrast Enhanced Mammography Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contrast Enhanced Mammography Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contrast Enhanced Mammography Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Contrast Enhanced Mammography Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
